Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaim

Showing results (761-770 of 763) with videos related to

Pageof 77
Sort By:
You have reached the last page of results.This site can display upto 763 results.
Vaccine|November 27, 2018
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analysesMarjahan Akhtar, Mohiul I Chowdhury, Taufiqur R Bhuiyan, et al.
The Lancet. Infectious Diseases|February 19, 2026
Efficacy of ETVAX, a vaccine against enterotoxigenic Escherichia coli-positive diarrhoea in Gambian children: a double-blind, randomised, placebo-controlled, phase 2b trialM Jahangir Hossain, Fatou Secka, Lady C Sanyang, et al.
Nature Biotechnology|May 2, 2025
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's diseaseRoger A Barker, Nicholas P Lao-Kaim, Natalie Valle Guzman, et al.
Pageof 77

Showing results (761-770 of 763) with videos related to

Sort By:
Pageof 77
You have reached the last page of results.This site can display upto 763 results.
Vaccine|November 27, 2018
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analysesMarjahan Akhtar, Mohiul I Chowdhury, Taufiqur R Bhuiyan, et al.
The Lancet. Infectious Diseases|February 19, 2026
Efficacy of ETVAX, a vaccine against enterotoxigenic Escherichia coli-positive diarrhoea in Gambian children: a double-blind, randomised, placebo-controlled, phase 2b trialM Jahangir Hossain, Fatou Secka, Lady C Sanyang, et al.
Nature Biotechnology|May 2, 2025
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's diseaseRoger A Barker, Nicholas P Lao-Kaim, Natalie Valle Guzman, et al.
Pageof 77